COMPARATIVE STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Fresh frozen versus autogenous iliac bone for the rehabilitation of the extremely atrophic maxilla with onlay grafts and endosseous implants: preliminary results of a prospective comparative study.

PURPOSE: The purpose of this study was to compare (1) the clinical outcome of the reconstruction of extremely atrophic edentulous maxillae with fresh frozen allogeneic bone (FFB) (group A) and autogenous bone (AB) (group B) iliac blocks; and (2) the peri-implant bone resorption and the survival rate of implants in the two groups.

MATERIALS AND METHODS: In a 1-year period, eight patients were treated with FFB and seven with AB iliac grafts. Five to seven months afterward, 108 implants were inserted (59 in group A and 49 in group B). Four to five months afterward, patients were rehabilitated with implant-supported prostheses. The mean follow-up was 24 months.

RESULTS: Prior to implant placement, graft exposure occurred in two patients in group A and in one patient in group B. The mean graft resorption prior to implant placement was 0.78 mm and 0.54 mm in group A and B, respectively. After implant placement, bone graft exposures with partial loss of the graft occurred in six out of eight patients in group A and in none of the group B patients. The survival rate of implants was 90.1% and 100% in group A and B, respectively. The mean values of peri-implant bone resorption at the end of the follow-up period were 1.64 mm and 0.92 mm in group A and B, respectively.

CONCLUSION: Results of this study seem to demonstrate that FFB does not represent a reliable alternative to AB blocks because of the higher rate of bone exposure and partial loss of the grafts, the lower implant survival, and the higher peri-implant bone resorption in FFB patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app